Myleran in treatment of chronic myeloid leukaemia.
作者信息
BLACKBURN E K, KING G M, SWAN H T
出版信息
Br Med J. 1956 Apr 14;1(4971):835-7. doi: 10.1136/bmj.1.4971.835.
Abstract
摘要
相似文献
1
Myleran in treatment of chronic myeloid leukaemia.
Br Med J. 1956 Apr 14;1(4971):835-7. doi: 10.1136/bmj.1.4971.835.
2
Myleran in chronic myeloid leukaemia.
Lancet. 1955 Feb 26;268(6861):425-30. doi: 10.1016/s0140-6736(55)90212-9.
3
Myleran in chronic myeloid leukaemia; results of treatment.
Lancet. 1953 Jan 31;264(6753):208-13. doi: 10.1016/s0140-6736(53)90885-x.
4
Myleran in chronic myeloid leukaemia; chemical constitution and biological action.
Lancet. 1953 Jan 31;264(6753):207-8. doi: 10.1016/s0140-6736(53)90884-8.
5
The use of myleran in the treatment of chronic myelocytic leukemia.
AMA Arch Intern Med. 1955 Oct;96(4):451-62. doi: 10.1001/archinte.1955.00250150025002.
6
Treatment of chronic granulocytic leukemia with myleran.
AMA Arch Intern Med. 1956 Mar;97(3):299-308. doi: 10.1001/archinte.1956.00250210045003.
7
Chemotherapy of leukaemia. I. Myleran in the treatment of chronic myeloid leukaemia.
S Afr Med J. 1956 Apr 14;30(15):357-60.
8
Myleran in the treatment of chronic myeloid leukaemia.
Acta Haematol. 1956 Sep;16(3):171-80. doi: 10.1159/000205125.
9
The treatment of chronic myeloid leukaemia with myleran.
Ir J Med Sci. 1957 Apr(376):186-9. doi: 10.1007/BF02952299.
10
[Casuistics on myleran treatment in chronic myelocytic leukemia].
Arch Kinderheilkd. 1956;153(3):251-4.
引用本文的文献
1
Residual effects of busulfan and irradiation on murine hematopoietic stem and progenitor cells.
Exp Hematol. 2022 Jan;105:22-31. doi: 10.1016/j.exphem.2021.11.001. Epub 2021 Nov 8.
2
Preclinical IV busulfan dose-finding study to induce reversible myeloablation in a non-human primate model.
PLoS One. 2018 Nov 29;13(11):e0206980. doi: 10.1371/journal.pone.0206980. eCollection 2018.
3
Busulphan in the treatment of chronic granulocytic leukaemia.
Br J Cancer. 1961 Sep;15(3):468-78. doi: 10.1038/bjc.1961.56.
4
The chemotherapy of malignant disease.
Br Med J. 1958 Jan 4;1(5061):1-7. doi: 10.1136/bmj.1.5061.1.
5
Medullary aplasia in chronic myeloid leukaemia during busulphan therapy.
Br Med J. 1957 Dec 21;2(5059):1468-71. doi: 10.1136/bmj.2.5059.1468.
6
Treatment of chronic myeloid leukaemia with mercaptopurine.
Br Med J. 1956 Dec 8;2(5005):1345-8. doi: 10.1136/bmj.2.5005.1345.
本文引用的文献
1
Myelocytic leukemia: an analysis of incidence, distribution and fatality, 1910-1948.
Ann Intern Med. 1951 Jul;35(1):194-212. doi: 10.7326/0003-4819-35-1-194.
2
Myleran (GT 41) in the treatment of leukaemia.
Acta Med Scand. 1955 Apr 16;151(4):295-306. doi: 10.1111/j.0954-6820.1955.tb10296.x.
3
The effect of 1,4-dimethanesulfonyloxybutane (GT-41 or myleran) upon leukemia.
Cancer. 1954 Mar;7(2):383-90. doi: 10.1002/1097-0142(195403)7:2<383::aid-cncr2820070225>3.0.co;2-v.
4
Myleran in chronic myeloid leukaemia; results of treatment.
Lancet. 1953 Jan 31;264(6753):208-13. doi: 10.1016/s0140-6736(53)90885-x.
5
Myleran in chronic myeloid leukaemia; chemical constitution and biological action.
Lancet. 1953 Jan 31;264(6753):207-8. doi: 10.1016/s0140-6736(53)90884-8.
Zotero 插件